As shown in Figure 10, A–E and Supplemental Figure 9, A and B, CTSGi treatment indeed attenuated the therapeutic effect and apoptosis induced by the drug combination in both CMT93 and MC38 Pik3ca-E545K–mutant tumor models. Here, PIK3CA is linked to neoplasm.